Virax Biolabs Group PEG Ratio

Virax Biolabs Group (VRAX) currently reports a PEG ratio of 0.68. That is below the sector sector average of 6.34. Use the charts on this page to explore Virax Biolabs Group's PEG ratio history and peer comparisons.

Virax Biolabs Group's PEG ratio of 0.68 is lower than the its sector sector average of 6.34. That is roughly 89.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Virax Biolabs Group's market price to a fundamental measure such as earnings, sales, or book value. At 0.68, VRAX can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 0.68, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 6.34. From there, open related valuation or income-statement pages for Virax Biolabs Group, and consider following VRAX for alerts when major investors trade the stock.